Mousssa Youdim (born in 1940) is a professor of neuroscience and the developer of the drug “Azilect”. He is the winner of the 2011 EMET Prize and the 2022 Israel Prize in the field of life sciences. The Israel Prize Committee stated that the award was given to Prof. Youdim in recognition of his pioneering, groundbreaking scientific achievements in the field of neuropharmacology. For decades, Prof. Youdim managed the Eve Topf Center for the Study of Neurodegenerative Diseases at the Rapaport Faculty of Medicine. He published about 800 articles on various topics related to the brain, brain diseases, and the nervous system. In recognition of his achievements Prof. Youdim has received the Technion’s Hershel Rich Prize, some 50 important international awards, and now also the Israel Prize.